Medical Device
ID: MRFR/MED/54736-HCR
200 Pages
Garvit Vyas
10/2025
ID: MRFR/MED/54735-HCR
200 Pages
Garvit Vyas
10/2025
ID: MRFR/MED/54733-HCR
200 Pages
Rahul Gotadki
10/2025
ID: MRFR/MED/54731-HCR
200 Pages
Garvit Vyas
10/2025
ID: MRFR/MED/54730-HCR
200 Pages
Garvit Vyas
10/2025
ID: MRFR/MED/54729-HCR
200 Pages
Garvit Vyas
10/2025
ID: MRFR/MED/54728-HCR
200 Pages
Garvit Vyas
10/2025
ID: MRFR/MED/54715-HCR
200 Pages
Garvit Vyas
10/2025
Spain Inflammatory Bowel Disease Treatment Market Research Report By Drug Type (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, Antibiotics), By Route of Administration (Oral, Injectable, Topical), By Disease Type (Ulcerative Colitis, Crohn's Disease) and By End User (Hospitals, Ambulatory Surgical Centers, Homecare Settings)- Forecast to 2035
ID: MRFR/MED/54714-HCR
200 Pages
Garvit Vyas
10/2025
China Inflammatory Bowel Disease Treatment Market Research Report: By Drug Type (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, Antibiotics), By Route of Administration (Oral, Injectable, Topical), By Disease Type (Ulcerative Colitis, Crohn's Disease) andBy End User (Hospitals, Ambulatory Surgical Centers, Homecare Settings)- Forecast to 2035
ID: MRFR/MED/54713-HCR
200 Pages
Garvit Vyas
10/2025
India Inflammatory Bowel Disease Treatment Market Research Report By Drug Type (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, Antibiotics), By Route of Administration (Oral, Injectable, Topical), By Disease Type (Ulcerative Colitis, Crohn's Disease) and By End User (Hospitals, Ambulatory Surgical Centers, Homecare Settings)- Forecast to 2035